{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:41:08Z","timestamp":1791895268517,"version":"4.3.4"},"reference-count":55,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Anaesth Intensive Care"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>The increasing prescription of glucagon-like peptide 1 (GLP-1) agonists presents a peri-operative challenge for anaesthetists. These drugs delay gastric emptying, potentially increasing pulmonary aspiration risk. Despite recent recommendations from the Australian and New Zealand College of Anaesthetists, Australian Society of Anaesthetists, and American Society of Anesthesiologists, there remain no formalised guidelines regarding preoperative optimisation for patients taking GLP-1 agonists. Given the current lack of evidence, we present a case series of incidents involving patients treated with GLP-1 agonists reported to webAIRS, a web-based anaesthetic incident reporting system in Australia and New Zealand. Among 11,700 reports from July 2009 to April 2024, 13 incidents related to GLP-1 agonist use were identified, including seven cases concerning aspiration. Patient factors potentially contributing to increased aspiration risks in these incidents included a higher body mass index, type 2 diabetes mellitus, gastro-oesophageal reflux disease, emergency case, and time from GLP-1 agonist cessation. Most incidents involved a rapid sequence induction for general anaesthesia with no cases utilising gastric ultrasound, preoperative nasogastric tube insertion, or intravenous erythromycin use. This case series highlights the potential concerns relating to GLP-1 treatment in the perioperative setting. Interdisciplinary collaboration and communication between anaesthetists, surgeons, general practitioners and endocrinologists are required to further investigate and establish preoperative guidelines for safe GLP-1 agonist use. Specifically, consideration in determining actual gastric contents of each patient despite generic fasting guidelines is needed. Early preoperative risk stratification should also improve patient safety and outcomes.<\/jats:p>","DOI":"10.1177\/0310057x241311597","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T08:33:00Z","timestamp":1743064380000},"page":"220-230","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["A case series of incidents reported to webAIRS relating to glucagon-like peptide 1 agonist use"],"prefix":"10.1177","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4668-7907","authenticated-orcid":false,"given":"Clayton YX","family":"Lam","sequence":"first","affiliation":[{"name":"Flinders Medical Centre, Department of Anaesthesia and Pain Medicine, Adelaide, Australia"},{"name":"Flinders University College of Medicine and Public Health, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0813-3161","authenticated-orcid":false,"given":"D-Yin","family":"Lin","sequence":"additional","affiliation":[{"name":"Flinders Medical Centre, Department of Anaesthesia and Pain Medicine, Adelaide, Australia"},{"name":"Flinders University College of Medicine and Public Health, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8804-4168","authenticated-orcid":false,"given":"Yasmin","family":"Endlich","sequence":"additional","affiliation":[{"name":"Royal Adelaide Hospital, Department of Anaesthesia and Pain Medicine, Adelaide, Australia"},{"name":"The University of Adelaide, Faculty of Medicine, Adelaide, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"e_1_3_5_2_2","unstructured":"Australian Institute of Health and Welfare. Type 2 diabetes https:\/\/www.aihw.gov.au\/reports\/diabetes\/diabetes\/contents\/how-common-is-diabetes\/type-2-diabetes (2023 accessed 26 April 2024)."},{"key":"e_1_3_5_3_2","unstructured":"Australian Institute of Health and Welfare. Medicine use: Australian Government https:\/\/www.aihw.gov.au\/reports\/diabetes\/diabetes\/contents\/treatment-and-management\/medicine-use (2023 accessed 10 July 2024)."},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1530\/EC-21-0130"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.52170"},{"key":"e_1_3_5_6_2","unstructured":"Australian Government: Department of Health and Aged Care. Pharmaceutical Benefits Scheme (PBS) https:\/\/www.pbs.gov.au\/pbs\/home (2024 accessed 7 May 2024)."},{"key":"e_1_3_5_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206038"},{"key":"e_1_3_5_8_2","doi-asserted-by":"crossref","unstructured":"Australian Prescriber. Tirzepatide for type 2 diabetes. Aust Prescr 2023; 46(4): 96\u20137. doi:10.18773\/austprescr.2023.028","DOI":"10.18773\/austprescr.2023.028"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.31128\/AJGP-07-21-6057"},{"key":"e_1_3_5_10_2","first-page":"498","article-title":"Liraglutide (victoza): The first once-daily incretin mimetic injection for type-2 diabetes","volume":"35","author":"Jackson SH","year":"2010","unstructured":"Jackson SH, Martin TS, Jones JD, et\u00a0al. Liraglutide (victoza): The first once-daily incretin mimetic injection for type-2 diabetes. P T 2010; 35: 498\u2013529.","journal-title":"P T"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp120168"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-021-09699-1"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-018-0668-z"},{"key":"e_1_3_5_14_2","first-page":"357","article-title":"Dulaglutide (Trulicity): The third once-weekly GLP-1 agonist","volume":"41","author":"Smith LL","year":"2016","unstructured":"Smith LL, Mosley JF2nd, Parke C, et\u00a0al. Dulaglutide (Trulicity): The third once-weekly GLP-1 agonist. P T 2016; 41: 357\u2013360.","journal-title":"P T"},{"key":"e_1_3_5_15_2","unstructured":"Australian Government Department of Health and Aged Care Therapeutic Goods Administration. Australian prescription medicine decision summaries https:\/\/www.tga.gov.au\/resources\/auspmd (2024 accessed 10 July 2024)."},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/asj\/sjad211"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1017\/cts.2023.612"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/9946924"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1043789"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2024.01.001"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2023.111091"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1177\/0310057X19854456"},{"key":"e_1_3_5_23_2","unstructured":"ANZCA FPM. PG07 Guideline on pre-anaesthesia consultation and patient preparation Appendix 1 2024 https:\/\/www.anzca.edu.au\/getattachment\/897f5bf5-b665-4c99-a56f-e72678f19f7e\/PG07(A)-Appendix-1-%E2%80%93-Fasting-guideline (2024 accessed 30 July 2024)."},{"key":"e_1_3_5_24_2","unstructured":"ANZCA. Clinical practice recommendation on periprocedural use of GLP-1\/GIP receptor agonists https:\/\/www.anzca.edu.au\/news\/glp-1-gip-receptor-agonists-clinical-practice-guid (2024 accessed 10 July 2024)"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/anae.16099"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-023-02550-y"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/EJA.0000000000001914"},{"key":"e_1_3_5_28_2","unstructured":"Australian Society of Anaesthetists. Perioperative management of patients on GLP-1 receptor agonists (GLP-1 RAs) https:\/\/asa.org.au\/wp-content\/uploads\/2024\/10\/ASA-FS1-Perioperative-Management-of-Patients-on-GLP-1-Receptor-Agonists-GLP-1-RAs.pdf?_cldee=ZUAOl5AOcYRXFKGjhKZthAI-xCD17NFnMbdjltjRhwOU3C1V6W9Igzzs2PTeFS1K&recipientid=contact-4e13d4a35113ef119f8a00224892bcfb-e0906d33ed204169a54ff7c34e489fea&esid=33d5ae6b-4d8f-ef11-8a69-002248981fac (2024 accessed 21 October 2024)."},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/0310057X211060846"},{"key":"e_1_3_5_30_2","unstructured":"ANZCA FPM. Anaesthetic incident reporting ANZCA2024 https:\/\/www.anzca.edu.au\/safety-advocacy\/standards-of-practice\/anaesthetic-incident-reporting (accessed 10 July 2024)."},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1177\/0310057X1704500105"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjae.2020.07.003"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2020.02.013"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-3-200508020-00006"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-022-05796-1"},{"key":"e_1_3_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.06.010"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108610"},{"key":"e_1_3_5_39_2","unstructured":"ANZCA FPM. Surgery warning on use of popular weight loss drugs https:\/\/www.anzca.edu.au\/resources\/media-releases\/2023-media-releases\/gastric-emptying-mr.pdf (2023 accessed 2 May 2024)."},{"key":"e_1_3_5_40_2","unstructured":"American Society of Anesthesiologists. American Society of Anesthesiologists consensus-based guidance on preoperative management of patients (adults and children) on glucagon-like peptide-1 (GLP-1) receptor agonists https:\/\/www.asahq.org\/about-asa\/newsroom\/news-releases\/2023\/06\/american-society-of-anesthesiologists-consensus-based-guidance-on-preoperative (2023 accessed 2 May 2024)."},{"key":"e_1_3_5_41_2","unstructured":"ANZCA FPM. PG07(A) Guideline on pre-anaesthesia consultation and patient preparation Appendix 1 2023 https:\/\/www.anzca.edu.au\/getattachment\/897f5bf5-b665-4c99-a56f-e72678f19f7e\/PG07(A)-Appendix-1-%E2%80%93-Fasting-guideline (2023 accessed 30 July 2024)."},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/anae.16306"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/bjaceaccp\/mki016"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjae.2019.09.001"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002788.pub3"},{"key":"e_1_3_5_46_2","first-page":"e49031","article-title":"Rapid evaluation of gastric content with ultrasound: An educational tool","volume":"15","author":"Nguyen H","year":"2023","unstructured":"Nguyen H, Paluska MR, Falcon R, et\u00a0al. Rapid evaluation of gastric content with ultrasound: An educational tool. Cureus 2023; 15: e49031. doi:10.7759\/cureus.49031","journal-title":"Cureus"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjae.2019.03.003"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thorsurg.2015.04.011"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2015.0306"},{"key":"e_1_3_5_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/bjaceaccp\/mkt053"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199710000-00008"},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-009-1076-x"},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13370"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.2174\/1574887111666160815103251"},{"key":"e_1_3_5_55_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2306963"},{"key":"e_1_3_5_56_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2307563"}],"container-title":["Anaesthesia and Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0310057X241311597","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/0310057X241311597","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0310057X241311597","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:13:07Z","timestamp":1777367587000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0310057X241311597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1177\/0310057X241311597"],"URL":"https:\/\/doi.org\/10.1177\/0310057x241311597","relation":{},"ISSN":["0310-057X","1448-0271"],"issn-type":[{"value":"0310-057X","type":"print"},{"value":"1448-0271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]}}}